These agents, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess different chemical architectures leading to their varying pharmacological actions. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily detected via its molecular formula – C14H15N6O4·H2SO4 – and characteristic luminescent properties observed in techniques such as mass spectrometry and infrared spectroscopy. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor inhibitor, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for total identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate malignancy treatment, can be verified through its particular mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) investigative data, ensuring its accurate chemical characterization.
Directory: Abacavir Sulfate Sulfate (CAS 188062-50-2) & Related Substances
Explore a extensive catalogue detailing Abacavir Disulfate Sulfate, identified by CAS number 188062-50-2, and a range of connected compounds. Our supply includes various grades to fulfill specific research and manufacturing ASPOXICILLIN 63358-49-6 requirements. Discover detailed specs including experimental results and existing quantities options. Furthermore, investigate a array of structurally akin materials that might be helpful in the current project. The listing is structured to aid streamlined procurement of pure pharmaceutical ingredients.
Drug Index: Abarelex and Abirateronum Acetate Chemical Abstract Service Identifiers
For chemists and medicinal professionals seeking precise pharmaceutical identification, accurate Chemical Abstract Service numbers are vital. Specifically, abarelix, a GnRH-releasing hormone agonist used in managing prostate disease, is designated the CAS code 65572-21-8. Furthermore, abiraterone acetate, a key drug in prostate disease, carries the Chemical Abstract Service identifier 389292-17-3. Careful notation and verification of these Chemical Abstract Service numbers are critical to guarantee correct compound identification and subsequent processes. This codes are widely obtainable through multiple research resources. Regularly check authorized references for the most information.
Drug Components: Abacavir Sulfate , Abarelix, Abiraterone Acetate, Registry Identifiers
The recognition of critical pharmaceutical compounds often relies on accurate chemical designations. Notably, this piece quickly addresses three significant examples: Abacavir Sulfate, a nucleoside reverse polymerase inhibitor; Abarelix, a hormone stimulator; and Abiraterone, utilized in malignant management. These molecule is connected with a unique Registry number, providing a universal method for identifying information and ensuring accurate communication within the research field. Refer the respective resources for full records and connected records.
Chemical Abstracts Service Number Database: Entries for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The extensive Chemical Abstracts Service (CAS) registry is an invaluable resource for researchers and industry professionals alike. This piece quickly explores information pertaining to three key therapeutic compounds: Abacavir Sulfate, a drug used to combat HIV; Abarelix, a medication used in treatment; and Abiraterone Acetate Salt, a powerful drug used in the treatment of metastatic advanced cancer. Finding the specific CAS number for each compound allows for unambiguous identification and supports precise scientific retrieval. These unique identifiers are necessary for data accuracy and uniform reporting across the field.
Utilizing Application Programming Interface Material Data: Compound Recognition with CAS Registry Numbers
Accurate product identification is paramount in the substance industry, and Application Programming Interface chemical data provides a robust solution. In particular, Chemical Abstracts Service numbers act as individual identifiers for substance compounds, allowing easy consolidation with repositories and platforms. Such approach not only improves information quality but as well as simplifies procedures related to investigation, purchase, and compliance documentation. Additionally, accessing this information via an API supports automation and reduces the chance for manual oversight.